Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
J Behav Health Serv Res ; 49(3): 262-281, 2022 07.
Article in English | MEDLINE | ID: covidwho-1872666


This study aims to describe which substance use service (SUS) organizations and who within these organizations support the maintenance of policies targeted at improving substance use treatment services. An online survey assessing respondent, organizational and program demographics, and knowledge and support regarding policy changes was distributed to all certified SUS and harm reduction programs in NYS. Bivariate and latent class analyses were used to identify patterns and associations to policy choices. Across the 227 respondents, there was a support for maintaining expansion of insurance coverage, virtual behavioral health/counseling and medication initiation/maintenance visits, reductions in prior authorizations, and access to prevention/harm reduction services. Three classes of support for policies were derived: (1) high-supporters (n = 49; 21%), (2) low-supporters (n = 66; 29%), and (3) selective-supporters. Having knowledge of policy changes was associated with membership in the high-supporters class. Implications regarding the role of knowledge in behavioral health policies dissemination structures, decision-making, and long-term expansion of SUS are discussed.

COVID-19 , Substance-Related Disorders , COVID-19/prevention & control , Health Policy , Humans , Insurance Coverage , New York , Substance-Related Disorders/therapy
J Subst Abuse Treat ; 133: 108550, 2022 02.
Article in English | MEDLINE | ID: covidwho-1284257


INTRODUCTION: Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. METHODS: Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. RESULTS: During the COVID-19 pandemic, policymakers shifted to more inclusive approaches of knowledge generation and co-production of recommendations. Barriers to adoption and implementation of new regulations included medication/services supply, lack of integration, stigma, and overcriminalization. CONCLUSION: Findings from this study highlight the potential feasibility and benefits of co-produced policies for substance use services and the need for consistent service supply, better integration with health care services, reduced stigma, improved funding structures, best practice guidelines, criminal justice reform, and harm reduction support. These considerations should inform future policy maintenance and modifications to substance use services related to COVID-19.

COVID-19 , Substance-Related Disorders , Humans , Pandemics , Policy , Policy Making , SARS-CoV-2
Psychol Trauma ; 12(S1): S111-S112, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-607254


The United States is facing both the coronavirus disease 2019 (COVID-19) pandemic and an ongoing epidemic of opioid overdose. Opioid use disorder is associated with other mental health problems, trauma, and social and health disparities. While the United States has acted to improve access to treatment for mental health and opioid use, research will be needed to understand the effectiveness of new policies in the context of COVID-19. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Coronavirus Infections/psychology , Drug Overdose/psychology , Opioid Epidemic , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/psychology , Pandemics , Pneumonia, Viral/psychology , Social Isolation , Adult , COVID-19 , Humans , Opiate Substitution Treatment , United States , United States Substance Abuse and Mental Health Services Administration